表观遗传修饰在血液癌症中的作用
Jovana Ilic1, Anna Bold1, Stefan Knop1
1Department of Hematology and Medical Oncology, Paracelsus Medical University, Nuremberg, Germany.
Frontiers in oncology
|February 23, 2026
概括
在DNA甲基化和基因组修饰的表观遗传改变是血液癌症的关键驱动因素. 了解基因表达中的这些变化对于向白血病,淋巴瘤和骨髓瘤至关重要.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 表观遗传调节,包括DNA甲基化和基因素修饰,控制基因表达和染色质结构.
- 这些表观遗传机制的失调与血液性恶性瘤的发展和进展有关.
- 表观遗传酶的突变改变了染色质,促进了癌症的发展,进化和耐药性.
研究的目的:
- 审查血液癌症中显著的表观遗传变化.
- 专注于DNA甲基化模式,基因素修饰酶和白血病,淋巴瘤和多发性骨髓瘤中的染色质重塑复合物.
- 总结这些表观遗传变化的对转录活性和瘤发生的影响.
主要方法:
- 关于血液癌症表观遗传变化的研究的文献综述.
- 对报告的DNA甲基化模式变化的分析.
- 检查基因组胺修饰酶和染色质重塑剂的突变和表达变化.
主要成果:
- 在各种血液癌症中观察到DNA甲基化模式的显著改变.
- 突变和基因组修饰酶和染色质重塑复合物的改变表达是突出的.
- 这些表观遗传变化深刻影响基因转录,推动瘤发生.
结论:
- 表观遗传失调是血液癌症发展和进展的关键因素.
- 针对表观遗传媒介提供了针对白血病,淋巴瘤和多发性骨髓瘤的潜在治疗策略.
- 对特定表观遗传变化的进一步研究可以阐明瘤发生和耐药性的机制.
更多相关视频
10:41An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
10.9K
13:47Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
26.5K
相关概念视频
Epigenetic Regulation
4.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.0K
Epigenetic Regulation
34.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.0K
Role of Hematopoietic Growth Factors
4.0K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.0K
Histone Modification
16.4K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.4K
Histone Modification
4.7K
4.7K
Regulation of Hematopoietic Stem Cells
4.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
